Cell-surface heparan sulfate facilitates human immunodeficiency virus Type 1 entry into some cell lines but not primary lymphocytes.
about
Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibitionRole of heparan sulfate in sexually transmitted infectionsHeparan Sulfate Proteoglycans Mediate Attachment and Entry of Human T-Cell Leukemia Virus Type 1 Virions into CD4+ T CellsCurrent concepts regarding the HTLV-1 receptor complex.Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: investigation of the mechanism of inhibition.CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cellsContribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.Development of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin.Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cellsA pH-sensitive heparin-binding sequence from Baculovirus gp64 protein is important for binding to mammalian cells but not to Sf9 insect cellsCellular Factors Involved in HTLV-1 Entry and PathogenicitHuman T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycansPolyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells.Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection.Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts.A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs.
P2860
Q27004059-E9878576-A2E4-4CCE-A842-606B734AC404Q27023959-1168AC43-A7E7-4645-8BC8-2C04B5F16D3EQ27472216-9ED38EDC-D138-4BFD-A0D5-3606FC0094C6Q33350169-63B404EB-4521-4759-8F3B-21AEE9AB4191Q33797964-802800D0-BAA9-43D7-AC7F-BA8F1CB5DDC1Q33840312-743E3BF0-A78D-412C-B024-E4CF7E823481Q33850612-EA9F1421-F121-4433-BBDD-6188EBE69268Q33874273-DA1AD656-8567-442B-A234-08D03A2B0897Q34193846-273369C9-0027-4DB9-BA71-CCEED60DC84EQ35155045-7B0A0678-C2A3-492E-A428-BD017616A589Q35634313-9B278472-8A94-4CA0-8DF4-22CE951326FEQ35666146-D476687A-E1C8-4C2A-B5F2-F62EBEECA5A7Q36049779-A76229DC-3825-4A78-8D33-1FA50C6EAB51Q36464718-34C05FFA-AB41-4967-946A-197770C3C22CQ36541239-8EBEA6E3-677C-4A81-93E7-833A9B18FEDBQ37099713-E8790FC5-386C-476F-A030-C4E4DEFEEF87Q39683774-8A788984-CAF7-487A-86A6-5A9A758B6876Q40133069-64134686-8F85-413E-BFB7-16A1846D2686Q40374556-C871AE4B-A89E-4F74-8315-5B3BAC12E4C2
P2860
Cell-surface heparan sulfate facilitates human immunodeficiency virus Type 1 entry into some cell lines but not primary lymphocytes.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Cell-surface heparan sulfate f ...... s but not primary lymphocytes.
@en
Cell-surface heparan sulfate f ...... s but not primary lymphocytes.
@nl
type
label
Cell-surface heparan sulfate f ...... s but not primary lymphocytes.
@en
Cell-surface heparan sulfate f ...... s but not primary lymphocytes.
@nl
prefLabel
Cell-surface heparan sulfate f ...... s but not primary lymphocytes.
@en
Cell-surface heparan sulfate f ...... s but not primary lymphocytes.
@nl
P2093
P1433
P1476
Cell-surface heparan sulfate f ...... es but not primary lymphocytes
@en
P2093
P304
P356
10.1016/S0168-1702(99)00018-0
P577
1999-04-01T00:00:00Z